Susquehanna International Group, LLP Cullinan Oncology, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 129,918 shares of CGEM stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
129,918
Previous 79,438
63.55%
Holding current value
$1.12 Million
Previous $601,000
62.73%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CGEM
# of Institutions
152Shares Held
66.6MCall Options Held
10.6KPut Options Held
917K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$66 Million11.28% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$49.6 Million1.7% of portfolio
-
Lynx1 Capital Management LP San Juan, PR4.4MShares$38 Million9.81% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.86MShares$33.3 Million0.67% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$30.6 Million0.0% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $394M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...